For the Inventor, By the Inventor

Enter assignee name

Le Plessis Robinson, France

Synthelabo

Calculating rank

USPTO Granted Patents = 252

CIPO Patents = 1

Trademarks = 2

Forward Citations = 2,348

Loading Chart...

Loading Chart...

238 inventors (with patents filed for the assignee):

Pascal George (44 out of 45 patents)

Philippe Michel Manoury (37 out of 39 patents)

Henry Najer (31 out of 31 patents)

4. Don Pierre Giudicelli (24 out of 24 patents)

5. Mireille Sevrin (21 out of 31 patents)

6. Jonathan Reid Frost (20 out of 23 patents)

7. Guy Rossey (18 out of 18 patents)

8. Alexander E Wick (16 out of 16 patents)

9. Thomas A Purcell (15 out of 15 patents)

10. Jean-Pierre Kaplan (15 out of 15 patents)

11. Jean Louis Binet (14 out of 21 patents)

12. Daniel C Obitz (14 out of 14 patents)

13. Jacques Froissant (13 out of 28 patents)

14. Samir Jegham (12 out of 39 patents)

15. Dennis C Bigg (12 out of 23 patents)

Core Competencies:

Pharmaceutical Compositions

Controlled Release

Therapeutic Uses

Oxazolidinone Derivatives

Serotonin Antagonists

Mizolastine

Alfuzosin

Benzofuran Derivatives

NSAIDs

Piperidine Derivatives

Ischemic Disorders

Glaucoma Treatment

252 patents: Sort by Forward Citations

1. 6214882 - Benzenesulphonamide derivatives, preparation thereof and therapeutical uses thereof (2001-04-10),

2. 6165507 - Slow-release pharmaceutical formulations containing mizolastine (2000-12-26),

3. 6149940 - Tablet with controlled release of alfuzosine chlorhydrate (2000-11-21),

4. 6143772 - Compounds derived from 3-(benzofuran-5-yl)oxazolidin-2-one, preparation (2000-11-07),

5. 6075021 - 1H-pyrido[3,4-b]indole-4-carboxamide derivatives, preparation and (2000-06-13),

6. 6069165 - Pharmaceutical compositions containing amisulpride and their therapeutic (2000-05-30),

7. 6063810 - 2-aminoethyl-benzofuran derivatives, preparation thereof and (2000-05-16),

8. 6060508 - Benzylamine derivatives, their preparation and their application in (2000-05-09),

9. D423784 - Toothbrush (2000-05-02),

10. 6056944 - Pharmaceutical compositions for oral use including an NSAID and ceramides (2000-05-02),

11. 6020352 - Treatment of ischemic disorders of the retina and optic nerve head (2000-02-01),

12. 5969146 - Oxazolidin-2-one derivatives, preparation method therefor and (1999-10-19),

13. D414937 - Toothbrush (1999-10-12),

14. 5958924 - Quinolein-2 (1H)-one derivatives as serotonin antagonists (1999-09-28),

15. 5929089 - 5-phenyl-3-(piperidin-4-yl)-1,3,4-oxadiazol-2(3H)-one derivatives for (1999-07-27),

Company Overview

Synthelabo is a pharmaceutical company based in Le Plessis Robinson, France, specializing in the development and manufacturing of innovative pharmaceutical formulations. The company focuses on advanced therapeutic applications, particularly in the areas of controlled release systems and pharmaceutical compositions. Synthelabo's expertise includes the research of oxazolidinone derivatives, serotonin antagonists, and compounds such as mizolastine and alfuzosin, contributing to the advancement of effective therapeutic solutions.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 27 2026

252 Patents

#1 in Le Plessis Robinson

#98 in France

#3,464 in the World

Le Plessis Robinson, France

Synthelabo

Forward Citations = 2,348

238 inventors:

Pascal George (44 out of 45 patents)

Philippe Michel Manoury (37 out of 39 patents)

Henry Najer (31 out of 31 patents)

4. Don Pierre Giudicelli (24 out of 24 patents)

5. Mireille Sevrin (21 out of 31 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Synthelabo. Retrieved from https://idiyas.com/company/synthelabo

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

Loading…